For example, both SCLC and NEPC exhibit concurrent genetic loss of tumor suppressors RB1 and TP53, as well as mutually exclusive expression of C‐MYC (MYC), N‐MYC (MYCN) or L‐MYC (MYCL).11 The gene discussed is MYCL; the disease is small cell lung carcinoma.